| 000 | 00821nam a2200253Ia 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20220926011751.0 | ||
| 006 | a|||||r|||| 00| 0 | ||
| 007 | ta | ||
| 008 | 220923b |||||||| |||| 00| 0 eng d | ||
| 037 | _cGeneral Book | ||
| 040 |
_aRTL _cRTL _beng |
||
| 041 |
_2eng _aeng |
||
| 082 | _aX:84, L3 | ||
| 100 |
_aGallein Qocar S. _9314858 |
||
| 245 | 0 | _aAccounting for research and development expenditur | |
| 260 |
_aNew York _bAICPA USA _c1973 |
||
| 300 |
_axii, 117p. Bib p 115-17 ; Appendix p 77-114 _ccm. |
||
| 490 | _aAmerican Institute of certified public accountants, Accounting Research Study.14 | ||
| 650 | _aTop Management | ||
| 700 |
_a Newman Maurico S. _9314859 |
||
| 942 |
_hX:84, L3 _cGB _2CC |
||
| 999 |
_c620875 _d620875 |
||